Nectar Lifesciences Limited (NECTAR LIFESCIENCES LTD.) aktie
NECLIFE.NS
NECTAR LIFESCIENCES LTD.
Market Cap
$2,340,844,800
Om Nectar Lifesciences Limited (NECTAR LIFESCIENCES LTD.) aktie
Nectar Lifesciences Limited manufactures, distributes, markets and sells pharmaceutical products in India and internationally. The company offers cephalosporins, includes pharmaceutical ingredients and intermediates comprising cefixime, cefuroxime axetil amorphous, cefuroxime axetil crystalline, cefotaxime sodium, ceftriaxone sodium, cefixime trihydrate, cefuroxime axetil, cefpodoxime proxetil and sterile, cefprozil, cefdinir, cefuroxime sodium, cefazolin sodium, ceftazidime pentahydrate, and cefepime +Arginine. It also provides contract manufacturing for finished dosage forms, such as tablets, capsules, dry powder oral suspensions, and granules and injectable for cephalosporins. In addition, the company offers menthol and pearl capsules. Nectar Lifesciences Limited was incorporated in 1995 and is headquartered in Chandigarh, India.
Företagsinformation
160002 Chandigarh, India
Analytikernas aktierekommendationer
Denna översikt ger en snabb insikt i hur analytiker bedömer aktiens potential baserat på deras senaste analyser och kursmål.